Product category:
Genomics
News Release from: Solexa | Subject: Genome Analysis System
Edited by the Laboratorytalk Editorial
Team on 20 July 2006
Solexa announces initial system
shipments
Solexa reports the first commercial shipments of the Solexa Genome Analysis System, the company's next-generation platform for DNA sequencing, expression profiling and small RNA analysis
The instrument shipments commenced in the second quarter and are the first in a series of anticipated shipments as part of Solexa's Early Access programme, which is expected to continue through summer 2006 "Solexa's technology is bringing genome sequencing to a new stage of development," said Eric Lander, director of the Broad Institute of MIT and Harvard in Cambridge, Massachusetts
This article was originally published on Laboratorytalk on 19 Oct 2006 at 8.00am (UK)
Related stories
Solexa announces sequencing of human X-chromosome
Results demonstrate that Genome Analysis System is achieving the data quality, read length and coverage uniformity required for discovering and characterising human sequence variation at genome level
Haematology analyser fills gap in range
With a throughput of 80 samples per hour, this will suit laboratories with workloads of up to 350 samples per day and fills the gap between 60 and 120 sample per hour machines
Innovative new products emphasise R and D
Completely new bench-top analyser combines the latest technological advances and a large test menu with a faster throughput
"Solexa's system promises to address economically and rapidly a broad range of genetic analysis applications, and we are excited to capitalise on that potential".
"The expected throughput, base-calling accuracy, and cost-effectiveness of the Solexa Genome Analysis System will allow us to tackle large-scale projects of several types, including whole human genome resequencing to compare cancerous and normal genomes," said Elaine Mardis, co-director of the Genome Sequencing Center (GSC) at the Washington University School of Medicine in St Louis, Missouri.
"We are delighted to work with this system in our facility and to build on the relationship we have with Solexa and its scientists".
The Early Access programme follows a period of collaboration during which scientists from a number of leading institutes, including the Wellcome Trust Sanger Institute in Cambridge, UK, the Broad Institute and the GSC, processed samples and analysed data from the system.
"Our ability to meet the aggressive timetable we set for ourselves marks a major achievement for Solexa, and is a testament to the dedication and hard work of our staff," said John West, Solexa's chief executive officer.
"We are delighted to have the opportunity to work with some of the world's leading genome institutes in the first phase of our Early Access programme.
"We look forward to building on our existing relationships with the personnel at these and other leading institutes to refine the protocols and applications of the Solexa Genome Analysis System and to advance the capabilities of the system to transform genetic analysis.".
• Solexa: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
